To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Split-Dose Dexamethasone Reduces Early PONV More Than Single Dose After TKA

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2025

Split-Dose Dexamethasone Reduces Early PONV More Than Single Dose After TKA

Vol: 307| Issue: 7| Number:58| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Perioperative Dexamethasone Split Between Two Doses Further Reduced Early Postoperative Nausea and Vomiting Than Single-Dose Dexamethasone: A Randomized Blinded Placebo-Controlled Trial.

J Arthroplasty . 2024 Dec;39(12):2954-2960.

Contributing Authors:
Y Chen D Niu Y Wang T Zhao W Xin Q Qian P Fu

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred fifty patients undergoing unilateral primary total knee arthroplasty for knee osteoarthritis were randomized to receive either placebo (Group A, n=50), a single 10 mg dose of dexamethasone preoperatively (Group B, n=50), or two 5 mg doses of dexamethasone pre- and postoperatively (Group C, n=50). The primary outcome was the incidence and severity of postoperative nausea and vomiting (P...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue